Global EditionASIA 中文雙語Fran?ais
    China
    Home / China / Health

    Country working on vaccines for novel coronavirus variants

    By ZOU SHUO and ZHANG YANGFEI | CHINA DAILY | Updated: 2021-03-29 07:18
    Share
    Share - WeChat
    Teachers and students are vaccinated at East China Normal University's Minhang campus stadium in Shanghai on Sunday. [Photo/XINHUA]

    Inoculations in use found to have a good neutralizing effect on strains

    China is advancing the development of COVID-19 vaccines against variants of the novel coronavirus, and experiments have shown the inactivated vaccines currently used in the country are effective against them.

    Zhang Yuntao, vice-president of China National Biotech Group, a subsidiary of State-owned pharmaceutical giant Sinopharm, told a news conference on Sunday that researchers have been testing the antiviral-mutation ability of the inactivated vaccines.

    By using data from mid-and late-stage clinical trials in China and overseas, researchers have conducted experiments on a dozen variants, including those found in South Africa and the United Kingdom, Zhang said.

    The experiments have found that the antibodies produced by the two inactivated vaccines have a good neutralizing effect on all the tested strains, he said, adding that such experiments are continuing on strains found in Brazil and Zimbabwe.

    Three inactivated vaccines have won conditional approval for market use in China. Two were developed and manufactured by Sinopharm and the other by Sinovac Biotech.

    Zhang said virus mutations will always occur and cannot be prevented, but small mutations will not alter the effectiveness of vaccines.

    Various COVID-19 variants have been identified since late last year. While no evidence has emerged that they cause more severe illness in the majority of infected people, they were found to be more contagious.

    Gao Qiang, general manager of Sinovac Biotech, told the news conference that the company has started research and development of vaccines against the variants discovered in South Africa and Brazil.

    Based on earlier cross-neutralization research on mutated strains found in 10 countries, its vaccine has proved to be effective, he said.

    The two executives said they have gained rich experience in vaccine research and development and will be able to respond quickly and effectively to mutant strains.

    Separately, China had administered more than 100 million doses of COVID-19 vaccines by Saturday, the National Health Commission said.

    The country will actively and prudently advance the COVID-19 vaccination of people over 60 and those who have chronic disease, based on the effectiveness of its mass vaccination campaign, commission official Wu Liangyou said.

    Beijing and Shanghai have started vaccinating people over 60 who are in good health and those who have chronic disease, Wu said.

    Zhang said China National Biotech Group will start consultations with the National Medical Products Administration on the vaccination of those aged between 3 and 17, and it is expected to start soon.

    The company started early and mid-stage clinical trials of vaccinations for people in that age group in Henan province last year, Zhang said.

    The trials have shown that the vaccine's safety met expectations, and data on its effectiveness has also been obtained, he said.

    Wang Huaqing, chief vaccination planning expert at the Chinese Center for Disease Control and Prevention, said although there is no comprehensive late-stage clinical trial data on vaccination of people under 18, it will be obtained as clinical trials progress.

    China has given consideration to vaccinating people under 18, including newborns, and it will continue to improve its vaccination plan based on the epidemic situation and clinical trial data, he said.

    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
     
    中文字幕丰满乱孑伦无码专区 | 无码国产精品一区二区免费式直播 | 99精品人妻无码专区在线视频区 | 中文无码不卡的岛国片| 国产午夜精华无码网站| 天堂√最新版中文在线| 精品久久久久久无码国产| 亚洲熟妇无码AV在线播放| 亚洲JIZZJIZZ中国少妇中文 | 亚洲中久无码不卡永久在线观看| 日韩精品无码视频一区二区蜜桃| 久久久噜噜噜久久中文福利| 国产精品午夜福利在线无码| 无码乱人伦一区二区亚洲一| 毛片免费全部播放无码| 中文字幕久久亚洲一区| A狠狠久久蜜臀婷色中文网| 亚洲AV无码一区二区三区国产| 无码精品人妻一区二区三区免费看 | 无码人妻一区二区三区兔费| 欧美日韩毛片熟妇有码无码 | 人妻少妇精品中文字幕AV | 日本中文字幕在线| 亚洲av无码成人精品区在线播放 | 67194成l人在线观看线路无码| 亚洲热妇无码AV在线播放| 久久亚洲AV无码精品色午夜| 最近2019中文字幕电影1| 熟妇人妻不卡中文字幕| 亚洲不卡中文字幕无码| 全球中文成人在线| 最近免费中文字幕MV在线视频3| 亚洲AV无码资源在线观看| 极品粉嫩嫩模大尺度无码视频| 国产av无码专区亚洲国产精品| 国产AV无码专区亚洲AVJULIA| 免费A级毛片av无码| 无码欧精品亚洲日韩一区| 无码AV中文字幕久久专区| 日韩AV无码久久一区二区| 精品久久久久久久无码|